Seminars in medicine of the Beth Israel Hospital, Boston - Clinical applications of research on angiogenesis

[1] VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) : 1480 - 1487

[2] [Anonymous], 1988, VASCULAR BIRTHMARKS

[3] BACHARACHBUHLES M, 1994, J INVEST DERMATOL, V103, P263

[4] Beattie G. J., 1994, ANN ONCOL, V5, p72a

[5] REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS [J]. SCIENCE, 1994, 264 (5158) : 569 - 571

[6] THE 16-KILODALTON N-TERMINAL FRAGMENT OF HUMAN PROLACTIN IS A POTENT INHIBITOR OF ANGIOGENESIS [J]. ENDOCRINOLOGY, 1993, 133 (03) : 1292 - 1299

[7] THALIDOMIDE IS AN INHIBITOR OF ANGIOGENESIS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) : 4082 - 4085

[8] CONTROL OF ANGIOGENESIS IN FIBROBLASTS BY P53 REGULATION OF THROMBOSPONDIN-1 [J]. SCIENCE, 1994, 265 (5178) : 1582 - 1584

[9] ANGIOGENESIS, NEOVASCULAR PROLIFERATION AND VASCULAR PATHOPHYSIOLOGY AS TARGETS FOR CANCER-THERAPY [J]. BRITISH JOURNAL OF RADIOLOGY, 1993, 66 (783) : 181 - 196

[10] Drummond A. H., 1995, Proceedings of the American Association for Cancer Research Annual Meeting, V36, P100

[1] VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) : 1480 - 1487

[2] [Anonymous], 1988, VASCULAR BIRTHMARKS

[3] BACHARACHBUHLES M, 1994, J INVEST DERMATOL, V103, P263

[4] Beattie G. J., 1994, ANN ONCOL, V5, p72a

[5] REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS [J]. SCIENCE, 1994, 264 (5158) : 569 - 571

[6] THE 16-KILODALTON N-TERMINAL FRAGMENT OF HUMAN PROLACTIN IS A POTENT INHIBITOR OF ANGIOGENESIS [J]. ENDOCRINOLOGY, 1993, 133 (03) : 1292 - 1299

[7] THALIDOMIDE IS AN INHIBITOR OF ANGIOGENESIS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) : 4082 - 4085

[8] CONTROL OF ANGIOGENESIS IN FIBROBLASTS BY P53 REGULATION OF THROMBOSPONDIN-1 [J]. SCIENCE, 1994, 265 (5178) : 1582 - 1584

[9] ANGIOGENESIS, NEOVASCULAR PROLIFERATION AND VASCULAR PATHOPHYSIOLOGY AS TARGETS FOR CANCER-THERAPY [J]. BRITISH JOURNAL OF RADIOLOGY, 1993, 66 (783) : 181 - 196

[10] Drummond A. H., 1995, Proceedings of the American Association for Cancer Research Annual Meeting, V36, P100